https://www.selleckchem.com/EGFR(HER).html
41log; range - 1.16 to - 4.54; Friedman p = 0.002) and day6 (- 3.20; range - 1.20 to - 6.77; Friedman p 0.001). There were no treatment-emergent adverse events, with no changes in oxygenation or hemodynamics during the 20-min treatments. One subject died 17days after enrollment due to intracranial hemorrhagic complications of anticoagulation while receiving extracorporeal membrane oxygenation. The remaining subjects clinically improved and scored 2, 4, 5, and 7 on the WHO scale at day30. In these subjects, clinical improvement correlated
Like
Comment
Share
